Published in Scand J Public Health on January 01, 2003
Physiological correlates of bereavement and the impact of bereavement interventions. Dialogues Clin Neurosci (2012) 0.95
Sleep and circadian rhythms in spousally bereaved seniors. Chronobiol Int (2008) 0.89
Fatal stroke after the death of a sibling: a nationwide follow-up study from Sweden. PLoS One (2013) 0.80
Sleep Disturbance in Bereavement. Psychiatr Ann (2008) 0.79
Identifying obstacles to participation in a questionnaire survey on widowers' grief. BMC Palliat Care (2010) 0.78
Intrinsic association of widowhood with mortality in community-dwelling older women and men: findings from a prospective propensity-matched population study. J Gerontol A Biol Sci Med Sci (2011) 0.77
The Impact of Sleep Disturbance on the Association Between Stressful Life Events and Depressive Symptoms. J Gerontol B Psychol Sci Soc Sci (2015) 0.76
The Sleep of the Bereaved. Sleep Hypn (2009) 0.76
Association between depressive symptoms and changes in sleep condition in the grieving process. Support Care Cancer (2014) 0.75
Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med (2011) 13.30
Radical prostatectomy or watchful waiting in early prostate cancer. N Engl J Med (2014) 10.06
Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet (2009) 6.91
Quality of life after radical prostatectomy or watchful waiting. N Engl J Med (2002) 6.83
Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet (2008) 6.69
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet (2013) 5.58
Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial. Lancet Oncol (2011) 5.28
Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes. BMJ (2014) 4.75
Talking about death with children who have severe malignant disease. N Engl J Med (2004) 3.92
Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12. Nat Genet (2008) 3.14
Long-term distress after radical prostatectomy versus watchful waiting in prostate cancer: a longitudinal study from the Scandinavian Prostate Cancer Group-4 randomized clinical trial. Eur Urol (2013) 2.84
Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat Genet (2009) 2.76
Individualized estimation of the benefit of radical prostatectomy from the Scandinavian Prostate Cancer Group randomized trial. Eur Urol (2012) 2.62
Polygenic risk score improves prostate cancer risk prediction: results from the Stockholm-1 cohort study. Eur Urol (2011) 2.62
Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden. Lancet Oncol (2010) 2.56
A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer. Nat Genet (2010) 2.56
Prostate-specific antigen levels as a predictor of lethal prostate cancer. J Natl Cancer Inst (2007) 2.49
Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up study. J Natl Cancer Inst (2010) 2.45
Suicide risk in men with prostate-specific antigen-detected early prostate cancer: a nationwide population-based cohort study from PCBaSe Sweden. Eur Urol (2009) 2.37
Surgery-related complications in 1253 robot-assisted and 485 open retropubic radical prostatectomies at the Karolinska University Hospital, Sweden. Urology (2010) 2.37
Surveillance and deferred treatment for localized prostate cancer. Population based study in the National Prostate Cancer Register of Sweden. J Urol (2008) 2.17
Multiple events of fractures and cardiovascular and thromboembolic disease following prostate cancer diagnosis: results from the population-based PCBaSe Sweden. Eur Urol (2011) 2.10
Epidemiology of urinary bladder cancer: from tumor development to patient's death. World J Urol (2007) 1.96
Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk. Hum Mol Genet (2009) 1.90
Cohort Profile: the National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0. Int J Epidemiol (2012) 1.88
Bias in odds ratios by logistic regression modelling and sample size. BMC Med Res Methodol (2009) 1.86
TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism. Proc Natl Acad Sci U S A (2013) 1.82
Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis (2003) 1.78
Outcome of primary versus deferred radical prostatectomy in the National Prostate Cancer Register of Sweden Follow-Up Study. J Urol (2010) 1.75
A hierarchical step-model for causation of bias-evaluating cancer treatment with epidemiological methods. Acta Oncol (2006) 1.73
Orgasm-associated urinary incontinence and sexual life after radical prostatectomy. J Sex Med (2011) 1.73
Incidence and prognosis of synchronous and metachronous bilateral breast cancer. J Clin Oncol (2007) 1.68
Parents' intellectual and emotional awareness of their child's impending death to cancer: a population-based long-term follow-up study. Lancet Oncol (2007) 1.67
A population-based nationwide study of parents' perceptions of a questionnaire on their child's death due to cancer. Lancet (2004) 1.64
Absolute and relative risk of cardiovascular disease in men with prostate cancer: results from the Population-Based PCBaSe Sweden. J Clin Oncol (2010) 1.62
Biochemical recurrence after robot-assisted radical prostatectomy in a European single-centre cohort with a minimum follow-up time of 5 years. Eur Urol (2012) 1.60
Inherited genetic variant predisposes to aggressive but not indolent prostate cancer. Proc Natl Acad Sci U S A (2010) 1.59
European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene. Hum Mol Genet (2011) 1.58
A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk. Eur Urol (2012) 1.55
Anxiety and depression in parents 4-9 years after the loss of a child owing to a malignancy: a population-based follow-up. Psychol Med (2004) 1.53
Symptoms 10-17 years after breast cancer radiotherapy data from the randomised SWEBCG91-RT trial. Radiother Oncol (2010) 1.50
Pilot testing of methods for evaluation of acupuncture for emesis during radiotherapy: a randomised single subject experimental design. Acupunct Med (2011) 1.49
Development of a new method for monitoring prostate-specific antigen changes in men with localised prostate cancer: a comparison of observational cohorts. Eur Urol (2009) 1.49
Anxiety is contagious-symptoms of anxiety in the terminally ill child affect long-term psychological well-being in bereaved parents. Pediatr Blood Cancer (2010) 1.48
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Hum Mol Genet (2012) 1.47
Defecation disturbances after cystectomy for urinary bladder cancer. BJU Int (2010) 1.46
Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer. Cancer Res (2009) 1.43
Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden. Radiother Oncol (2011) 1.42
Inguinal hernia after radical prostatectomy for prostate cancer: results from a randomized setting and a nonrandomized setting. Eur Urol (2010) 1.39
Prognosis of patients with breast cancer: causes of death and effects of time since diagnosis, age, and tumor characteristics. J Clin Oncol (2011) 1.39
[In Process Citation]. Lakartidningen (2015) 1.38
Care-related distress: a nationwide study of parents who lost their child to cancer. J Clin Oncol (2005) 1.38
Quitline in smoking cessation: a cost-effectiveness analysis. Int J Technol Assess Health Care (2004) 1.34
Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer. Prostate (2009) 1.33
Genetic analysis of the RNASEL gene in hereditary, familial, and sporadic prostate cancer. Clin Cancer Res (2004) 1.32
Patient-rating of distressful symptoms after treatment for early cervical cancer. Acta Obstet Gynecol Scand (2002) 1.28
Obesity and treatment of diabetes with glyburide may both be risk factors for acute pancreatitis. Diabetes Care (2002) 1.25
Inherited genetic markers discovered to date are able to identify a significant number of men at considerably elevated risk for prostate cancer. Prostate (2010) 1.20
The National Prostate Cancer Register in Sweden 1998-2002: trends in incidence, treatment and survival. Scand J Urol Nephrol (2005) 1.20
Systematic replication study of reported genetic associations in prostate cancer: Strong support for genetic variation in the androgen pathway. Prostate (2006) 1.19
Effects of prostate-specific antigen testing on familial prostate cancer risk estimates. J Natl Cancer Inst (2010) 1.17
PCBaSe Sweden: a register-based resource for prostate cancer research. Scand J Urol Nephrol (2009) 1.17
Preparatory studies to a population-based survey of suicide-bereaved parents in Sweden. Crisis (2013) 1.16
Detecting homozygous deletions in the CDKN2A(p16(INK4a))/ARF(p14(ARF)) gene in urinary bladder cancer using real-time quantitative PCR. Clin Cancer Res (2003) 1.16
Association of frequent consumption of fatty fish with prostate cancer risk is modified by COX-2 polymorphism. Int J Cancer (2007) 1.15
Coding counsellor behaviour in motivational interviewing sessions: inter-rater reliability for the Swedish Motivational Interviewing Treatment Integrity Code (MITI). Cogn Behav Ther (2007) 1.15
Long-term outcomes for mothers who have or have not held their stillborn baby. Midwifery (2007) 1.13
A test of the validity of the motivational interviewing treatment integrity code. Cogn Behav Ther (2008) 1.12
Self-assessed health, sadness and happiness in relation to the total burden of symptoms from the lower urinary tract. BJU Int (2005) 1.09
Insulin glargine use and short-term incidence of malignancies - a three-year population-based observation. Acta Oncol (2011) 1.09
Genetic variants and family history predict prostate cancer similar to prostate-specific antigen. Clin Cancer Res (2009) 1.09
Distressful symptoms and well-being after radical cystectomy and orthotopic bladder substitution compared with a matched control population. J Urol (2002) 1.08
Social correlates of cigarette smoking among Icelandic adolescents: a population-based cross-sectional study. BMC Public Health (2008) 1.07
Dietary intake of heterocyclic amines and cancers of the esophagus and gastric cardia. Cancer Epidemiol Biomarkers Prev (2003) 1.06
Clinician acquisition and retention of Motivational Interviewing skills: a two-and-a-half-year exploratory study. Subst Abuse Treat Prev Policy (2010) 1.05
Tobacco smoking and long-lasting symptoms from the bowel and the anal-sphincter region after radiotherapy for prostate cancer. Radiother Oncol (2011) 1.04
Smoking cessation in general practice: the effects of a quitline. Nicotine Tob Res (2006) 1.02
Model selection in medical research: a simulation study comparing Bayesian model averaging and stepwise regression. BMC Med Res Methodol (2010) 1.01
A population-based study of 538 patients with newly detected urinary bladder neoplasms followed during 5 years. Scand J Urol Nephrol (2003) 1.01
One third of patients with radiotherapy-induced nausea consider their antiemetic treatment insufficient. Support Care Cancer (2008) 1.00
Distressful symptoms after radical radiotherapy for urinary bladder cancer. Radiother Oncol (2002) 1.00
Self-reported symptoms of faecal incontinence among long-term gynaecological cancer survivors and population-based controls. Eur J Cancer (2009) 1.00
Impact of comorbidity on management and mortality in women diagnosed with breast cancer. Breast Cancer Res Treat (2012) 0.99
Prostate cancer diagnosed after prostate-specific antigen testing of men without clinical signs of the disease: a population-based study from the National Prostate Cancer Register of Sweden. Scand J Urol Nephrol (2010) 0.98
How can we make cancer survival statistics more useful for patients and clinicians: an illustration using localized prostate cancer in Sweden. Cancer Causes Control (2013) 0.97
Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based study. Breast Cancer Res Treat (2012) 0.97
Mortality among men with locally advanced prostate cancer managed with noncurative intent: a nationwide study in PCBaSe Sweden. Eur Urol (2011) 0.96
Symptoms affecting children with malignancies during the last month of life: a nationwide follow-up. Pediatrics (2006) 0.96
Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005-2010: a population-based study from the national Swedish kidney cancer register. Scand J Urol (2014) 0.96
Age-specific trends of survival in metastatic breast cancer: 26 years longitudinal data from a population-based cancer registry in Stockholm, Sweden. Breast Cancer Res Treat (2011) 0.96
Age at surgery, educational level and long-term urinary incontinence after radical prostatectomy. BJU Int (2011) 0.95
Can individuals identify if needling was performed with an acupuncture needle or a non-penetrating sham needle? Complement Ther Med (2008) 0.95
Bereaved siblings' perception of participating in research--a nationwide study. Psychooncology (2011) 0.95
Tumor stage affects risk and prognosis of contralateral breast cancer: results from a large Swedish-population-based study. J Clin Oncol (2012) 0.94
Treatment of nausea and emesis during cancer chemotherapy. Discrepancies between antiemetic effect and well-being. J Pain Symptom Manage (2002) 0.94